wish your sex life more happy!

-------------get more sex life information,please visit hi138.com

News Category Menu

*Han Dynasty bricks
*Transgender man claims pr
*Torchbearer Daga displays
*Hsu Chi: Sexy baby in sum
*Tenorio Volcano National
*Esthonian Ambassador dona
*Gigi Leung on UN mission
*Lanterns decorate hutong
*Salute Boy in 5.12 Quake
*Hainan prepares for BFA a
*Jay Chou holds fund-raisi
*Zhangs win Worlds silver
*Zhang Ziyi runs with the
*Andy Lau visits survivors
*Snow hits NW China grassl

Home > siteMap > pain

U.S. FDA Issues Action Letter For Sugammadex

Schering-Plough Corporation (NYSE: SGP) announced that the U.S. Food and Drug Administration (FDA) has issued a not-approvable letter for sugammadex sodium injection for the reversal of muscle r...

Cadence Pharmaceuticals Announces FDA Concurrence With Clinical Development Plan For Acetavance(TM)

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that it has received written guidance from the U.S. Food and Drug Administration (FDA) that one post-operative pain trial (Sinatra Study) and one...

UCB Receives Not-Approvable Letter From FDA For Lacosamide For Diabetic Neuropathic Pain

UCB announced that it received a not-approvable letter from the U.S. Food and Drug Administration (FDA) for lacosamide for the treatment of diabetic neuropathic pain in adults. The company will seek...

BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant Binding Agent - Approved In European Union

Schering-Plough Corporation (NYSE: SGP) announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA) and the f...

UK To Host 12th World Congress On Pain

Over 5,000 of the world's leading scientific and medical experts will visit the UK this summer for the World Congress on Pain, an event which is expected to bring over 拢10m of economic benefit to the ...

Cartilage Repair Gel Under Development, Which Will Improve Quality Of Life For People Suffering With Medical Joint Trouble

Neuropathic Pain - NSL-043 Achieves Success In Phase I Multiple Ascending Dose Trial

First U.S. Patient Undergoes Non-Invasive Magnetic Resonance Guided Focused Ultrasound Procedure To Relieve Pain From Bone Metastases

Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain In A U.S. Phase 2 Trial In Women With Moderate To Severe Endometriosis

NeurogesX Initiates Dosing In Phase 1 Clinical Trial For NGX-1998 Capsaicin Liquid Formulation

Study Of Surgical Option For Treating Diabetic And Other Neuropathies Launched By UT Southwestern

Mundipharma Submits New Analgesic Targin (Prolonged Release Oxycodone / Naloxone Combination) For European Approval

Mundipharma Submits New Analgesic Targin(R) (Prolonged Release Oxycodone / Naloxone Combination) For European Approval

Low Back Pain Recovery Slow; And Worse For Those On Compensation

Why Having An Anaesthetic Is Such A Pain

SCOLR Pharma, Inc. Advances Extended-Release Ibuprofen With Initiation Of Clinical Study

Canadian Scientists Report On Pain Research At NIDCR's 60th Anniversary Symposium